Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 22Neoplasms 20Lung Neoplasms 10Colorectal Neoplasms 8Uterine Cervical Neoplasms 6Papillomavirus Infections 5Head and Neck Neoplasms 5Fatigue 5Multiple Myeloma 4Lymphoma 4Hematologic Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Prostatic Neoplasms 3Melanoma 3Hematopoietic and Lymphoid System Neoplasm 3Gastrointestinal Neoplasms 3Sleep Wake Disorders 2Skin Cancer Prevention 2Obesity 2Neoplasm Metastasis 2Motor Activity 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hematopoietic and Lymphatic System Neoplasm 2Diabetes Mellitus 2Depression 2Caregiver 2Cancer Survivor 2

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Abnormalities, Radiation-Induced × Educational Status × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡